AIAnthropic1h ago
Anthropic details early drug development work with six partners
Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy
TL;DRAnthropic is partnering with six companies and acquiring Mithril to explore AI for drug discovery.
Why it matters: Shows AI moving beyond hype into biotech infrastructure, potentially accelerating real therapeutic development pipelines.
There are many opportunities to speed up drug development, even beyond the most commonly discussed applications of AI, like proposing initial designs for new molecules.
Read full articleSource: Anthropic · Opens in new tab